AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Kimberly C Breen

Examiner Kimberly C Breen appears to be very difficult relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 12.9%, they average 2.80 office actions per granted patent, and their rejection profile leans toward §103 and occasional §101 rejections.

Difficulty vs AU Very Hard
Difficulty vs Group Very Hard
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.80
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2022-2026)
Phone
(571) 272-0980
Predicted Supervisor
Melenie Gordon
Supervisor Phone
(571) 272-8037
Tech Center
1600 - Biotechnology and Organic
Group
1650 - Enzymology, Microbiology, and Fermentation

Metrics

Applications Evaluated
116
Granted Applications
15
Non-Granted Applications
101
Avg OA / Grant
2.80
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1657
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 12.9% 2.80
Art Unit 35 47.1% 2.07
Group 207 41.1% 2.01
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 7 2 28.6%
2023 14 1 7.1%
2024 28 8 28.6%
2025 46 4 8.7%
2026 21 0 0.0%

15 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 115 8.7% 4.3% 47.0% 3.5%
2 84 9.5% 3.6% 46.4% 4.8%
3 57 3.5% 1.8% 50.9% 10.5%
4 37 0.0% 2.7% 45.9% 16.2%
5 21 0.0% 0.0% 47.6% 19.0%
6 14 0.0% 0.0% 57.1% 14.3%
7 6 16.7% 0.0% 33.3% 0.0%
8 4 0.0% 25.0% 25.0% 0.0%
9 2 0.0% 0.0% 50.0% 0.0%
10 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
38.1%
2022
7.9%
2023
3.8%
2024
1.0%
2025
4.8%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.